4//SEC Filing
PROVECTUS BIOPHARMACEUTICALS, INC. 4
Accession 0001140361-14-010099
$PVCTCIK 0000315545operating
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 10:11 AM ET
Size
8.4 KB
Accession
0001140361-14-010099
Insider Transaction Report
Form 4
CULPEPPER PETER R
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2014-02-26$1.10/sh+68,624$75,486→ 1,012,332 total - Exercise/Conversion
Common Stock
2014-02-26$1.10/sh+121,000$133,100→ 121,000 total(indirect: By 401(k)) - Exercise/Conversion
Stock Option (right to buy)
2014-02-26+189,624→ 0 totalExercise: $1.10From: 2004-02-26Exp: 2014-02-26→ Common Stock (189,624 underlying)
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000315545
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 10:11 AM ET
- Size
- 8.4 KB